Boston, MA, February 4, 2015 – Fish & Richardson has been named “IP Practice Group of the Year” by Law360 for the size, complexity, and significance of its 2014 litigation wins. Fish was singled out “for the third year in a row by doing more of the same: winning major patent cases ...and continuing to lead the pack in the aggressive use of new post-grant review proceedings.”
According to Law360, Fish “won a slew of high-profile patent cases in both tech and pharma” including “a Federal Circuit ruling defeating infringement claims against Apple and LG Electronics and a trial court victory for Allergan Inc. to protect a $400-million eye medication.” The publication highlighted the firm’s “advantage” in having attorneys “who both specialize in trying cases and have deep technical expertise in a given field.” (Click here to view article.)
“Fish has both a large number of technically trained lawyers and a deep bench of seasoned trial lawyers. That means we can create a team with exactly the right people for every case, jurisdiction, technology, and industry,” said Ann Cathcart Chaplin, Litigation Practice Group Leader at Fish & Richardson. “We work with thousands of the world’s largest and most innovative companies. They trust us with their most important business objectives because we provide strategic counseling and litigation services that protect and maximize the value of their intellectual property.”
Law360 lauded Fish’s appellate win for client Fresenius, which took 10 years, two trials, three Federal Circuit appeals, and a USPTO reexamination before Fresenius was freed from a $150 million liability. This was a precedential case in which the Federal Circuit made clear that post-grant review can directly impact the outcome of patent litigation. In May 2014, the U.S. Supreme Court declined to review the Federal Circuit’s ruling, which has led to broad changes in the manner that patentees and defendants strategize around patent litigation.
As Law360 noted, “It isn't a coincidence that Fish was involved in an important case that fleshed out the law on post-grant proceedings, which have taken on increased significance since several new procedures were added in the America Invents Act.”
Fish has appeared in 184 post-grant matters since November 2013, which accounts for 11 percent of those filed. “The firm won three such proceedings on behalf of Micron Technology Inc. against patents held by the University of Illinois. A month later, the Federal Circuit affirmed another such victory, this one defeating a bid by St. Jude Medical to invalidate patents held by Fish client Volcano Corp,” said Law360.
“Post-grant proceedings have become a key weapon in patent infringement disputes,” said Cathcart Chaplin. “These cases show the value of synergy between trial teams and patent prosecution teams. It is a winning combination few firms can match.”
Fish & Richardson is a global patent, intellectual property (IP) litigation, and commercial litigation law firm with more than 400 attorneys and technology specialists across the U.S. and Europe. Fish has been named the #1 patent litigation firm in the U.S. for 11 consecutive years. Fish has been winning cases worth billions in controversy – often by making new law – for the most innovative clients and influential industry leaders since 1878. For more information, visit www.fr.com.
# # #